FDA Approved: PEDMARK — Original Application (Fennec Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved PEDMARK (sodium thiosulfate) from Fennec Pharmaceuticals in an original NDA to prevent cisplatin-induced hearing loss in pediatric patients receivi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cisplatin-induced Ototoxicity

Drugs mentioned

• Pedmark (sodium thiosulfate)

Snippet

ORIG AP for PEDMARK (SODIUM THIOSULFATE)